Merck Sharp & Dohme LLC
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Merck Sharp & Dohme LLC is a clinical trial sponsor. It has 231 active clinical trials with 172,412 planned participants, across 17 therapeutic areas. Since 2021 it has completed 473 trials and stopped 74 early.
Trial track record · since 2021
Pipeline · 231 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
11 approved drug applications with a product on the market.
Questions about Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC is lead sponsor of 231 active clinical trials on ClinicalTrials.gov, with 172,412 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 473 trials and stopped 74 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Merck Sharp & Dohme LLC; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.
Approve Suite is not affiliated with Merck Sharp & Dohme LLC.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.